Navigation Links
United States Gives $12 Million to Pediatric AIDS Foundation Initiative
Date:1/24/2008

HARARE, Zimbabwe, Jan. 24 /PRNewswire-USNewswire/ -- The American people, through the United States Agency for International Development (USAID) launched a new $12.5 million HIV/AIDS initiative in Zimbabwe. The initiative, expected to dramatically increase access for women and children to vital HIV prevention services, will be implemented by the Elizabeth Glaser Pediatric AIDS Foundation.

The U.S. contribution to the Zimbabwe Family AIDS Initiatives, a part of the overall U.S. President's Emergency Plan for AIDS Relief, will expand Zimbabwe's national mother-to-child transmission prevention program. It will also provide greater access to prevention and treatment services for pregnant women and infants, and undertake important operational research to identify innovative solutions to challenges that the national program still faces today. The initiative will directly support the National AIDS & TB Unit sites throughout the country, with the goal of helping 460,000 pregnant women access important anti-retroviral medications. The new initiative is also supported by other donors such as the United Kingdom's Department for International Development, the United States Centers for Disease Control and Prevention, the Bill and Melinda Gates Foundation, and Johnson & Johnson.

During the recent launch ceremony, U.S. Ambassador to Zimbabwe James McGee highlighted the successful collaborative efforts supported by the US Government. "The United States will continue to join and assist Zimbabweans in the battle against HIV/AIDS," said Ambassador McGee. "It will take commitment and strong leadership to overcome the challenges that we are all facing and, together, in strong partnership, we will make a difference."

Elizabeth Glaser and its three implementing partners - JF Kapnek Trust, the Organization for Public Health Interventions and Development (OPHID), and the Zimbabwe AIDS Prevention Project - have been providing direct support to more than 330 Ministry of Health and Child Welfare health facilities, in over 24 districts of Zimbabwe. Through their programs, more than 280,000 pregnant women have gained access to services. About 34,000 women living with HIV have been identified within the program, and the majority of these women and their infants have received anti-retroviral treatments.

Only one in every three HIV positive pregnant women in Zimbabwe is currently receiving the services that can protect their babies from the virus. As a result, more than 17,300 children each year become infected in Zimbabwe. USAID's Mission Director to Zimbabwe, Karen Freemen said, "The Elizabeth Glaser program's achievements are a culmination of a multitude of efforts by the U.S. government, its partners, donors, and the thousands of health care workers whose dedication to patient care and service sustains these programs."

The Elizabeth Glaser Pediatric AIDS Foundation is a worldwide leader in the fight against pediatric AIDS. To learn more about the Foundation's work in Zimbabwe, visit http://www.pedaids.org/OurWork/InternationalPrograms/Zimbabwe.aspx.

For more information about USAID and its HIV AIDS programs in Zimbabwe, visit http://www.usaid.gov/our_work/global_health/aids/Countries/africa/zimbabwe. html.

Public Information: 202-712-4810

http://www.usaid.gov


'/>"/>
SOURCE U.S. Agency for International Development
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
2. United States continues to have highest level of health spending
3. United Medicorp, Inc.s Shareholders Approve All Proposals
4. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
5. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
6. Peoples United Financial CEO Has Surgery
7. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
8. More Than 100 Organizations Call for a National AIDS Strategy to End the Epidemic in the United States
9. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
10. Universal Health Care Coverage in the United States
11. Women Deliver Conference to Feature United Nations Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , ... January 20, 2017 , ... "TransFlare 4K Mystique ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have ...
(Date:1/20/2017)... ... ... Chocolate Biscuit”: a biographical account following a man who went on to support his country ... Ivey, born in Lynn Haven, Florida and at the age of 5, his family moved ... he joined the Navy and got married right out of boot camp. , He ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting ... of published author, Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted ... idea of writing a book has been in the back of my mind for years, ...
(Date:1/19/2017)... ... January 20, 2017 , ... Today, the Centers for ... in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who participate in ... APMs are an important part of the Administration’s effort to build a system that ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... With the cold weather here, many people ... Snow blowers are efficient when clearing large amounts of snow, but they can be dangerous ... the U.S. Consumer Product Safety Commission for the proper use of snow blowers:, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: